Summary
Overview
Work history
Education
Skills
Websites
LANGUAGES
REFERENCES
Strategic Initiatives & Leadership Projects
Accomplishments
Affiliations
Timeline
Generic

Alaaeldin Salah

Jeddah,Saudi Arabia

Summary

Strategic Commercial Executive with 15+ years of experience accelerating growth across the MEA pharmaceutical sector. Expert in full P&L ownership and leading high-impact teams to steer diverse portfolios—from Specialty Biological treatment and Branded Generics to mass-market Consumer Health. Adept at navigating complex regulatory landscapes to design and execute scalable strategies that secure sustainable advantage across the Kingdom and emerging markets.

Overview

15
15
years of professional experience
5
5
years of post-secondary education

Work history

Export Sales Manager-Consumer Health

Jamjoom Pharmaceuticals Factory Co.
Jeddah, Saudi Arabia
01.2025 - Current
  • Strategic P&L & Growth Leadership: Hold full P&L accountability for Consumer Health export division, charged with its exponential scaling. Developed and am executing strategic roadmap to grow business from 5.8M SAR base (2024) to 15M SAR (2025), in close partnership with Finance to model profitability and secure budgets.
  • Architect of Market Expansion & Business Models: Designing and executing division's expansion blueprint. This includes dual-path strategy for rapid capture of partnership-driven markets (Libya, Yemen, Somalia) and systematic build-out of regulated corridors (Iraq, Egypt, Morocco). Spearheading fundamental business model transformation in Jordan, Lebanon, and UAE, shifting from direct sales to full-service distribution partnership model to enhance scale and efficiency.
  • Gulf Core Market Optimization: Directing optimization and growth strategy for foundational Gulf markets (Kuwait, Bahrain, UAE, Oman). Focused on resolving critical supply chain gaps, managing inventory, and securing key tenders (e.g., Kuwait) to maximize portfolio performance and protect core revenue.
  • End-to-End New Market Commercialization: Directly accountable for launch and financial success of new markets, with clear revenue targets ($1.8M in Iraq, $1.3M in Morocco by 2026). Oversee creation of launch portfolio projected to generate $4.5M USD within its first year, orchestrating all cross-functional efforts from regulatory filing to financial modelling.
  • Team Leadership & Operational Governance: Building division's leadership capability by directly managing two regional supervisors (Iraq and Gulf). Establishing operational governance for scalable growth, including building playbook for market entry, partner due diligence, and supply chain setup.

Export Sales Manager – JP Portfolio, Other Markets

Jamjoom Pharmaceuticals Factory Co.
Jeddah, KSA
06.2022 - 12.2024
  • Strategic P&L & Portfolio Leadership: Held full P&L ownership for multi-region export portfolio, translating corporate strategy into 3-year growth roadmap. Consistently delivered 112-107% of annual targets while driving 35-71% year-over-year market growth, establishing new profitability benchmarks through direct contract negotiations and pricing strategies.
  • Architect of Market Expansion & Regulatory Strategy: Designed and executed market entry and expansion blueprint across 10+ regions,, encompassing both current market penetration and new market entries (e.g., Ghana, East Africa, Kazakhstan). Directed all cross-functional efforts to secure critical regulatory milestones, such as EAEU GMP certification from MOH Kazakhstan, to unlock and de-risk expansion.
  • Commercial Transformation & Business Model Innovation: Drove strategic shift in commercial operations by reengineering foundational business models across diverse countries. This transformation involved creating new distribution channels, implementing distributor-centric commercial policy, and restructuring key supply partnerships (e.g., with Al Basar Charity Organization) to build scalable, resilient platform.
  • High-Performance Culture & Strategic Capability Building: Fostered culture of excellence and accountability by mentoring sales managers and country heads. Instituted data-driven planning and forecasting processes that enhanced operational precision and directly informed development of integrated 3-year commercial strategies, building long-term organizational capability.

Consumer Health- National Sales Manager

Jamjoom Pharmaceuticals Factory Co.
Jeddah, KSA
05.2023 - 06.2024
  • Launched & Scaled a New Brand: Led the full P&L and launch of JP's Probiotics, driving it to the #2 market position (IQVIA) within seven months and exceeding the first-year sales target by 103%.
  • Built a Data-Driven Market Strategy: Created the division's first private market stakeholder map (pharmacies, hospitals, insurers), turning it into a blueprint for targeted partnerships and maximizing coverage.
  • Achieved Dominant Market Access: Secured product listing and partnerships to achieve retail coverage in over 90% of target pharmacy chains and key private hospitals, building a resilient commercial foundation.
  • Led Integrated Launch Campaigns: Directed unified launch campaigns across Jeddah, Riyadh, and Dammam, aligning Medical Affairs, Marketing, and Sales teams for a high-impact market entry.
  • Systematized Operations & Team Growth: Instituted data-driven processes for planning and execution, while implementing the team's first development plan to build strategic capabilities for sustainable growth.

Business Development Manager

Dermica Laboratories
Riyadh, KSA
06.2021 - 05.2022
  • Business Unit Growth Strategy: Steered a ~40 million SAR aesthetic/therapeutic business across KSA and Gulf markets, exceeding annual objectives by 135% in 2022 through strategic portfolio expansion.
  • Strategic Innovation & Market Creation: Pioneered next-generation aesthetic technologies by founding the Kingdom's first Exosome Advisory Board with key dermatologists, establishing clinical authority and accelerating market adoption.
  • Clinical-Market Strategy & Evidence Generation: Advanced exosomes from aesthetics to therapeutics, co-initiating a clinical trial and directing a national wound healing project to build scientific evidence for new indications.
  • High-Performance Team & Deep Market Penetration: Led a team of four managers to engineer deep market penetration, conducting 65+ advanced workshops and orchestrating a launch event for 120+ dermatologists to drive commercial results.
  • Integrated Commercial Execution & Expansion: Executed strategy through Gulf regulatory alignment, distribution optimization, and data-driven insights to maximize market share.

National Immunology Sales Manager-Dermatology

AbbVie Biopharmaceutical Company
Riyadh, KSA
03.2019 - 05.2021
  • Medical-Market Strategy & Guideline Leadership: Exercised market-shaping influence by collaborating with KSA Dermatology Society to co-author first national treatment guidelines for Psoriasis and PsA . This established IL-23 class as standard of care, creating durable, science-backed foundation for long-term portfolio dominance.
  • Accelerated Market Access & Portfolio Commercialization: Secured decisive first-mover advantage by driving Saudi MOH portfolio registration within 8 months , architecting bridge initiatives and formulary strategy that accelerated patient access and revenue capture ahead of competitors.
  • Data-Driven Commercial Architecture: Engineered commercial launch model by leading SKYHATS analytics project to map stakeholders and segment accounts. This enabled resource-efficient, hyper-targeted go-to-market strategy based on formulary status and competitive dynamics, maximizing ROI.
  • Integrated Cross-Functional Execution: Orchestrated Integrated Franchise Team (IFT) framework, fostering high-impact collaboration between Medical Affairs, Marketing, and Market Access to ensure strategic alignment and maximize commercial impact of SKYRIZI launch and brand story .

Sales Manager-Immunology (Humira)

AbbVie Biopharmaceutical Company
Riyadh, KSA
03.2016 - 03.2019
  • Portfolio Strategy & Multi-Channel Leadership: Held national strategic and commercial accountability for Humira dermatology portfolio across KSA. Drove growth and defended market leadership by executing integrated strategies for institutional, private, and MOH hospital channels, directly impacting brand P&L.
  • Complex New Indication Launches: Led end-to-end commercial strategy for expanding Humira's therapeutic footprint: orchestrating multi-year launch for Hidradenitis Suppurativa and cross-specialty launch for Uveitis (collaborating with Ophthalmology and Rheumatology KOLs), successfully accessing new patient populations.
  • Market-Shaping Influence & Stakeholder Strategy: Acted as primary architect of brand's market presence by organizing national speaker tours and convening key advisory boards with payers, pharmacists, and dermatologists. This direct engagement shaped treatment paradigms, facilitated market access, and informed high-level brand strategy.
  • High-Performance Team & Strategic Capability Development: Built and led high-performing national and regional teams. Focused on developing strategic business acumen and leadership skills within team, implementing programs that enhanced commercial excellence and prepared talent for larger roles.

Senior Product Specialist-Immunology Business Unit

AbbVie Biopharmaceutical Company
Central Region, KSA
09.2014 - 03.2016
  • Proven Account Manager who exceeded CEX-SFE benchmarks in call rate and coverage to drive growth and manage key accounts, including Main TPH and MOH.

Product Specialist-Immunology Business Unit

AbbVie Biopharmaceutical Company
South Region, KSA
01.2012 - 09.2014
  • Achieved 'Best Achiever' status for the HUMIRA Immunology Business Unit in 2 of 3 years by consistently exceeding sales targets in the Southern territory. Built enduring customer partnerships and leveraged deep market knowledge to execute tailored strategies that drove growth and market penetration.

Medical Representative

Glaxosmithkline
Cairo
10.2010 - 12.2011
  • Consistently surpassed sales targets across four consecutive quarters.
  • Achieved a 35% growth in market share during 2011.

Education

MBA - Marketing

International Business Academy of SWITZERLAND
SWITZERLAND
01.2021 - 12.2024

Bachelor's - Pharmaceutical Sciences

AIN SHAMS UNIVERSITY
Cairo, Egypt

Diploma - Soft skills

Powerful Insights
Cairo
01.2022 - 12.2022

Skills

  • Strategic P&L & Commercial Leadership: Full profit-and-loss accountability, budget development, and driving revenue growth from concept to market leadership
  • Cross-Functional Leadership & Orchestration: Aligning and directing Medical Affairs, Marketing, Finance, Regulatory, and Supply Chain to execute integrated business strategies
  • Global Market Strategy & Expansion: Architecting and executing market entry, scaling operations, and managing diverse regulatory and competitive landscapes across MEA regions
  • Business Model Transformation: Re-engineering commercial and distribution models to enhance scalability, coverage, and profitability
  • High-Performance Team Development: Building, mentoring, and leading commercial teams to exceed targets and develop future leaders

LANGUAGES

Arabic
Native
English
Advanced

REFERENCES

  • Essam, Gameel, General Manager Consumer health and export markets at Jamjoom Pharmaceutical, +96654054040, Jamjoom Pharmaceutical
  • Mohamed, Abubakr, Regional Vice President MiddleEast, Africa & Russia CIS at AbbVie, +966503248261, AbbVie
  • Ahmed, Majed, Global Marketing Franchise Head/ Director HIV, Hepatitis, and Women Health Abbott Diagnostics., +12243015909, Abbott Diagnostics
  • Nabil, Sabry, Country Pharma Manager at Gulf Neo Care Saudi Arabia, +966504423147, Gulf Neo Care Saudi Arabia
  • Mohammad, Al Labadi, Project Consultant Biosimilars at Amgen, 00966553331967, Amgen

Strategic Initiatives & Leadership Projects

  • Jamjoom Pharma Digital Repository for International Agreements (Nov 2022)
    Role/Initiative: Spearheaded the creation of a centralized digital repository.
    Strategic Purpose: To standardize and streamline the management of all international market agreements, ensuring compliance and facilitating efficient global trade operations.
    Impact: Established a unified platform as the cornerstone for regulating commercial relationships and fostering international cooperation.
  • SKYHATS (AbbVie) – Key Account Archetype Strategy (Nov 2020)
    Role/Initiative: Led the SKYHATS initiative to design a strategic segmentation model.
    Strategic Purpose: To analyze and segment Key Accounts based on formulary status and competitive activity, determining the most effective strategy, tactics, and messaging per archetype.
    Impact: Enhanced IFT (Integrated Franchise Team) efficiency by providing a data-driven framework for tailored account engagement.
  • EXPERIZI 15 (AbbVie) – Accelerated Team Development Program (Jun 2020)
    Role/Initiative: Founded and championed an internal knowledge-transfer initiative.
    Strategic Purpose: To accelerate the development of new team members by systematically transferring business knowledge and daily task expertise from senior members in focused 15-minute weekly sessions.
    Impact: Built team capability and reduced onboarding time, fostering a culture of continuous learning and mentorship.
  • IFT-Developmental Guide (AbbVie) – In-Field Team Excellence Framework (Oct 2017)
    Role/Initiative: Contributed to the development of a key excellence framework.
    Strategic Purpose: To improve cross-functional 'ways of working' across in-field teams with the goal of increasing value delivered to stakeholders.
    Impact: Aimed at improving health outcomes by enhancing team collaboration and strategic alignment.

Accomplishments

  • AbbVie President's Award (Highest Company Honor) – 2017, 2018, 2019, 2020
    Recognized for best-in-class brand team performance , including excellence in the Hidradenitis Suppurativa (HS) launch .
  • Multi-Year "Best Achiever" Accolades – 2013, 2014, 2015, 2017
    Named top performer for Immunology line (all indications) , Dermatology line , and as Sales Manager , consistently achieving 118-145% of sales and patient targets .
  • Prestigious "Star Award" – 2014, 2018
    Received the company's "most eminent recognition" for exceptional contributions and market-shaping projects.
  • Key Career Milestones
    Promoted to Field Sales Supervisor
    (2016) based on demonstrated leadership and performance.
    Critical Market Access Achievement : Recognized for the successful inclusion of Humira in all MOH-Medical supplies (2014).

Affiliations

  • International cinema, football tactics, and language learning.

Timeline

Export Sales Manager-Consumer Health

Jamjoom Pharmaceuticals Factory Co.
01.2025 - Current

Consumer Health- National Sales Manager

Jamjoom Pharmaceuticals Factory Co.
05.2023 - 06.2024

Export Sales Manager – JP Portfolio, Other Markets

Jamjoom Pharmaceuticals Factory Co.
06.2022 - 12.2024

Diploma - Soft skills

Powerful Insights
01.2022 - 12.2022

Business Development Manager

Dermica Laboratories
06.2021 - 05.2022

MBA - Marketing

International Business Academy of SWITZERLAND
01.2021 - 12.2024

National Immunology Sales Manager-Dermatology

AbbVie Biopharmaceutical Company
03.2019 - 05.2021

Sales Manager-Immunology (Humira)

AbbVie Biopharmaceutical Company
03.2016 - 03.2019

Senior Product Specialist-Immunology Business Unit

AbbVie Biopharmaceutical Company
09.2014 - 03.2016

Product Specialist-Immunology Business Unit

AbbVie Biopharmaceutical Company
01.2012 - 09.2014

Medical Representative

Glaxosmithkline
10.2010 - 12.2011

Bachelor's - Pharmaceutical Sciences

AIN SHAMS UNIVERSITY
Alaaeldin Salah